Carmelo Laface

467 total citations
34 papers, 291 citations indexed

About

Carmelo Laface is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carmelo Laface has authored 34 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Carmelo Laface's work include Cancer Immunotherapy and Biomarkers (8 papers), Advanced Breast Cancer Therapies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Carmelo Laface is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Advanced Breast Cancer Therapies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Carmelo Laface collaborates with scholars based in Italy, Albania and Türkiye. Carmelo Laface's co-authors include Mariarita Laforgia, Cosmo Damiano Gadaleta, Girolamo Ranieri, Francesca Ambrogio, Michele Ammendola, Caterina Foti, P. De Santis, Palma Fedele, Anna Santoro and Patrizia Nardulli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Carmelo Laface

29 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmelo Laface Italy 11 121 92 87 47 39 34 291
Francesca Sparano Italy 9 219 1.8× 113 1.2× 103 1.2× 78 1.7× 22 0.6× 19 369
Nikolai Schleußner Germany 5 138 1.1× 96 1.0× 41 0.5× 42 0.9× 24 0.6× 9 286
Qiuyun Luo China 9 116 1.0× 188 2.0× 39 0.4× 56 1.2× 16 0.4× 24 310
Chen-Yu Hu China 12 85 0.7× 214 2.3× 41 0.5× 55 1.2× 43 1.1× 19 371
Ruiqi Wu China 6 94 0.8× 149 1.6× 44 0.5× 139 3.0× 39 1.0× 8 315
Yaqun Li China 5 182 1.5× 106 1.2× 58 0.7× 113 2.4× 9 0.2× 10 320
Jia Fan China 12 90 0.7× 149 1.6× 27 0.3× 37 0.8× 36 0.9× 28 324
Kang Qin China 10 165 1.4× 151 1.6× 223 2.6× 26 0.6× 28 0.7× 18 393
Yasuhiro Terazaki Japan 12 191 1.6× 182 2.0× 112 1.3× 105 2.2× 14 0.4× 21 425

Countries citing papers authored by Carmelo Laface

Since Specialization
Citations

This map shows the geographic impact of Carmelo Laface's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmelo Laface with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmelo Laface more than expected).

Fields of papers citing papers by Carmelo Laface

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmelo Laface. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmelo Laface. The network helps show where Carmelo Laface may publish in the future.

Co-authorship network of co-authors of Carmelo Laface

This figure shows the co-authorship network connecting the top 25 collaborators of Carmelo Laface. A scholar is included among the top collaborators of Carmelo Laface based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmelo Laface. Carmelo Laface is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ambrogio, Francesca, Teresa Perillo, Domenico Bonamonte, et al.. (2025). Successful Treatment of MEK Inhibitor-Induced Paronychia in Neurofibromatosis with Photodynamic Therapy: A Case Report and Review of the Therapeutic Options. Journal of Clinical Medicine. 14(4). 1104–1104.
2.
Laface, Carmelo, et al.. (2025). Corneal Perforation as a Possible Ocular Adverse Event Caused by Cabozantinib: A Clinical Case and Brief Review. Journal of Clinical Medicine. 14(12). 4052–4052.
3.
Laface, Carmelo, et al.. (2025). HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies. SHILAP Revista de lepidopterología. 5(1). 9–9.
4.
Laface, Carmelo, Angela Dalia Ricci, Alessandro Rizzo, et al.. (2024). Autotaxin–Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications. International Journal of Molecular Sciences. 25(14). 7737–7737. 6 indexed citations
5.
Laface, Carmelo, et al.. (2024). Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2– breast cancer. Dermatology Reports. 17(2).
6.
7.
Ambrogio, Francesca, Domenico Bonamonte, Raffaele Filotico, et al.. (2023). Photodynamic Therapy Used to Treat an HIV Patient with an Efflorescence of Viral Warts after HAART Therapy. Diagnostics. 13(6). 1098–1098. 4 indexed citations
8.
Laface, Carmelo, Riccardo Memeo, Anna Santoro, et al.. (2023). Immunotherapy and Pancreatic Cancer: A Lost Challenge?. Life. 13(7). 1482–1482. 11 indexed citations
9.
Laface, Carmelo, Francesco Giuliani, Assunta Melaccio, et al.. (2023). The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions. Journal of Clinical Medicine. 12(18). 6012–6012. 1 indexed citations
10.
Giuliani, Francesco, Carmelo Laface, Assunta Melaccio, et al.. (2023). Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives. Current Oncology. 30(6). 5769–5794. 13 indexed citations
11.
Cazzato, Gerardo, Teresa Lettini, Anna Colagrande, et al.. (2023). Immunohistochemical Expression of Programmed Cell Death Ligand 1 (PD-L1) in Human Cutaneous Malignant Melanoma: A Narrative Review with Historical Perspectives. Genes. 14(6). 1252–1252. 1 indexed citations
12.
13.
Tricarico, Domenico, et al.. (2022). Inflammatory Related Reactions in Humans and in Canine Breast Cancers, A Spontaneous Animal Model of Disease. Frontiers in Pharmacology. 13. 752098–752098. 8 indexed citations
14.
Ambrogio, Francesca, Carmelo Laface, Daniela Loconsole, et al.. (2022). Peri-oral Monkeypox Virus Infection: A Clinical Report with Confirmatory Polymerase Chain Reaction Findings. Vaccines. 11(1). 36–36. 3 indexed citations
15.
Ambrogio, Francesca, Carmelo Laface, Federico Perosa, et al.. (2022). An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis. Internal and Emergency Medicine. 17(8). 2339–2341. 1 indexed citations
16.
Laface, Carmelo, et al.. (2022). Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. Cancers. 14(16). 4028–4028. 41 indexed citations
17.
Ammendola, Michele, Giuseppe Currò, Carmelo Laface, et al.. (2021). Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue. Cells. 10(2). 444–444. 17 indexed citations
18.
Patruno, Rosa, Giuseppe Passantino, Carmelo Laface, et al.. (2020). Microvascular Density, Endothelial Area, and Ki-67 Proliferative Index Correlate Each Other in Cat Post-Injection Fibrosarcoma. Cells. 10(1). 31–31. 6 indexed citations
19.
Ranieri, Girolamo, Carmelo Laface, Mariarita Laforgia, et al.. (2020). Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study. Frontiers in Oncology. 10. 590707–590707. 13 indexed citations
20.
Laface, Carmelo, Michele Ammendola, Valeria Zuccalà, et al.. (2020). Mast cells positive to c-kit receptor and to tryptase in normal to cancer pancreatic tissue and the correlation with angiogenesis.. Journal of Clinical Oncology. 38(15_suppl). e16502–e16502. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Sparano Breakdown of academic impact, for papers by Nikolai Schleußner Breakdown of academic impact, for papers by Qiuyun Luo Breakdown of academic impact, for papers by Chen-Yu Hu Breakdown of academic impact, for papers by Ruiqi Wu Breakdown of academic impact, for papers by Yaqun Li Breakdown of academic impact, for papers by Jia Fan Breakdown of academic impact, for papers by Kang Qin Breakdown of academic impact, for papers by Yasuhiro Terazaki
Rankless by CCL
2026